RobertArthurKratzkeMD
Oncology • Minneapolis, MNThoracic Cancer
Professor, Medicine, University of Minnesota Medical School
Dr. Kratzke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
424 Harvard St Se
Masonic Cancer Center, First Floor, Suite M100
Minneapolis, MN 55455Phone+1 612-625-5411
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1983 - 1986
University of Washington School of MedicineClass of 1983
Certifications & Licensure
MN State Medical License 1998 - 2025
WI State Medical License 1984 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers Start of enrollment: 2008 Dec 01
- Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107 Start of enrollment: 2005 Nov 01
Publications & Presentations
PubMed
- 22 citationsTriptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesotheliomaBlake A. Jacobson, Esther Z. Chen, Shaogeng Tang, Holly Sedgwick Belgum, Joel McCauley
Genes & Cancer. 2015-03-01 - 55 citationsIn cerebrospinal fluid ER chaperones ERp57 and calreticulin bind β-amyloidRichard R. Erickson, Lisa M. Dunning, Douglas Olson, Sheftel J. Cohen, Alan T. Davis
Biochemical and Biophysical Research Communications. 2005-06-24 - 5 citationsNonlinear association between body mass index and overall survival in advanced NSCLC patients treated with immune checkpoint blockade.Aditya Jain, Shijia Zhang, Ryan M Shanley, Naomi Fujioka, Robert A Kratzke
Cancer Immunology, Immunotherapy. 2023-05-01
Journal Articles
- LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry Based Biomarkers in Resected Non-Small Cell Lung CancerRobert Kratzke, MD, Clinical Lung Cancer
Press Mentions
OncLive® Presents State of the Science Summit™ on Lung CancerAugust 1st, 2019
Masonic Cancer Center Professor Elected Chair of the Big Ten Cancer Research Consortium Steering CommitteeDecember 23rd, 2016
Grant Support
- Protocol Review &Monitoring SystemNational Cancer Institute2009–2012
- CDK Inhibitors And Response To DHAC In MesotheliomaNational Cancer Institute2000–2001
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
